Continuous Renal Replacement Therapy Market Report 2026

Continuous Renal Replacement Therapy Market Overview

• Continuous Renal Replacement Therapy market size has reached to $1.73 billion in 2025 • Expected to grow to $2.77 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Chronic Kidney Disease Incidence Fuels Continuous Renal Replacement Therapy Market Expansion • Market Trend: Advancements In Continuous Renal Replacement Therapy For Enhanced Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Continuous Renal Replacement Therapy Market?

Continuous renal replacement therapy (CRRT) is a type of dialysis that provides slow, continuous blood filtration to help regulate fluid, electrolyte, and waste levels in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It helps manage fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal by intermittent hemodialysis due to cardiovascular instability. The main continuous renal replacement therapy products are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device used in the treatment of critically ill patients with acute kidney injury (AKI) or other renal conditions. It offers both renal and non-renal therapies of different modalities, such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (cvvhd), and continuous venovenous hemodiafiltration (cvvhdf). It is used for adults, pediatrics, and neonates by several end-users, including hospitals, ambulatory care, and homecare.

What Is The Continuous Renal Replacement Therapy Market Growth Forecast?

The continuous renal replacement therapy market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to aging population with higher aki risk, increasing burden of critical illnesses, growing adoption of advanced renal support technologies, rising focus on individualized critical care treatment, expansion of intensive care capacity in emerging markets. Major trends in the forecast period include rising adoption of CRRT in intensive care units, increasing use of continuous therapies for hemodynamically unstable patients, growing demand for precision fluid and electrolyte management, expansion of CRRT use in pediatric and neonatal care, increasing preference for integrated CRRT systems and consumables.

Global Continuous Renal Replacement Therapy Market Segmentation

1) By Product: System, Consumables 2) By Therapy: Renal, Non-Renal 3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF) 4) By Age Group: Adults, Pediatrics Or Neonates 5) By End-Users: Hospitals, Ambulatory Care Subsegments: 1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets 2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets

What Is The Driver Of The Continuous Renal Replacement Therapy Market?

The increasing incidence of chronic kidney diseases is expected to propel the growth of the continuous renal replacement therapy market going forward. Chronic kidney disease (CKD) is a long-term condition where the kidneys progressively lose function over time, leading to impaired filtration of waste products from the blood. The rising incidence of chronic kidney diseases is influenced by lifestyle changes, aging populations, and increasing rates of diabetes and hypertension. Continuous renal replacement therapy is utilized in chronic kidney disease for acute exacerbations or complications to manage fluid balance and continuously remove metabolic waste products. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a U.S.-based national public health agency, more than 1 in 7 adults in the US, over 35.5 million people, are estimated to have chronic kidney disease (CKD). Notably, nearly 90% of these individuals remain unaware of their condition, underscoring a significant gap in early detection and awareness efforts for CKD in the US. Therefore, the increasing incidence of chronic kidney diseases is driving the growth of the continuous renal replacement therapy industry.

Key Players In The Global Continuous Renal Replacement Therapy Market

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Toray Medical Co. Ltd., Kawasumi Hemofiltration Inc.

Global Continuous Renal Replacement Therapy Market Trends and Insights

Major companies operating in the continuous renal replacement therapy market are focused on developing innovative renal therapy options for dialysis patients to enhance treatment efficacy, improve patient outcomes, and reduce complications associated with traditional dialysis methods. This innovative therapy operates continuously, typically over 24 hours, and is gentler on the body compared to standard dialysis, making it suitable for patients with acute kidney injuries or severe health conditions. For instance, in January 2023, according to a report published by Peconic Bay Medical Center (PBMC), a US-based medical center that offers medical services, including emergency care and, surgical services, launched a new renal therapy option for dialysis patients. The therapy is designed to be more comfortable for patients who may not tolerate standard dialysis due to their medical conditions. CRRT is administered more slowly than traditional dialysis, which helps minimize stress on critically ill patients.

What Are Latest Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market?

In August 2024, Baxter International Inc., a US-based healthcare company specializing in manufacturing medical products, acquired The Carlyle Group Inc. for $3.8 billion. With this acquisition, Carlyle Group aims to enhance its portfolio in the renal care thereby positioning itself to leverage the growing demand for innovative dialysis products and services that support patients with chronic kidney disease. The Carlyle Group Inc., is a US-based investment firm that specializes in continuous renal replacement therapy.

Regional Outlook

North America was the largest region in the continuous renal replacement therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Continuous Renal Replacement Therapy Market?

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.